A PHASE 3, RANDOMIZED, DOUBLE-BLIND, MULTICENTRE STUDY TO EVALUATE THE SAFETY AND EFFICACY OF TAK-438 20 MG ONCE DAILY COMPARED TO LANSOPRAZOLE 30 MG ONCE DAILY IN PATIENTS WITH EROSIVE ESOPHAGITIS: RESULTS FROM A CHINESE SUB-COHORT

Minhu Chen  1     Ning Dai  2     Guijun Fei  3     Chui Fung Chong  4     Nobuo Funao  5     Shutian Zhang  6    
1 The First Affiliated Hospital, Sun Yat-sen University,Guangzhou,China
2 Sir Run Run Shaw Hospital,Zhejiang,China
3 Peking Union Medical College Hospital,Beijing,China
4 Takeda Pharmaceutical Company Ltd,Singapore,Singapore
5 Takeda Pharmaceutical Company Ltd.,Osaka,Japan
6 Beijing Friendship Hospital, Capital Medical University,Beijing,Chi

Conference
UEG Week 2018

Citation
United European Gastroenterology Journal 2018; 6 (Supplement 1)


Login to access library content

Login

Do you need help setting up your myUEG account?
Contact us at [email protected]

New to myUEG?

Create myUEG account

Forgot your password?

Reset myUEG password

Social Sharing